NCT00436072 - ZD6474, Cetuximab, and Irinotecan in Patients With Metastatic Colorectal Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

February 29, 2012

Study Completion Date

August 31, 2012

Conditions

Colorectal Cancer

Interventions

DRUG

ZD6474

Orally on a daily basis

DRUG

Cetuximab

Infusion once weekly

DRUG

Irinotecan

Infusion once the safe dose of ZD6474 and cetuximab is established

Trial Locations (3)

Beth Israel Deaconess Medical Center, Boston

Dana-Farber Cancer Institute, Boston

Massachusetts General Hospital, Boston